Yeahka Announces 2024 Interim Results
Strengthened Commercialization across Payments and Digital Commerce EcosystemRemarkable Overseas Expansion Progress Wider AI Technology Application HONG KONG, Aug. 28, 2024 /PRNewswire/ — Yeahka Limited (“Yeahka” or the “Company,” Stock Code: 9923.HK), a leading payme
Serve Robotics Announces Pricing of Private Placement & Warrant Exercise for aggregate gross proceeds of $20 Million
SAN FRANCISCO, Aug. 27, 2024 /PRNewswire/ — Serve Robotics Inc. (“Serve” or “Company”) (Nasdaq: SERV), a leading autonomous sidewalk delivery company, announced today that the Company has entered into a securities purchase agreement expected to result in gross proceeds
European Commission Approves Astellas’ PADCEV™ (enfortumab vedotin) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Urothelial Cancer
– First regimen approved in advanced urothelial cancer to demonstrate superiority to platinum-containing chemotherapy, the standard of care for nearly 40 years1 – European Marketing Authorization based on positive overall survival and progression-free survival results from the global Ph
Inaugural Southern Shaolin Wing Chun Competition Wraps Up in China
FUQING, China, Aug. 27, 2024 /PRNewswire/ — A news report by Huanqiu.com The Southern Shaolin Temple in Fuqing, a city steeped in the annals of Chinese martial history, recently concluded the first World Southern Shaolin Wing Chun Competition. The event was more than a martial arts tourname
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
MELBOURNE, Australia, Aug. 28, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-CDx, (Pixclara®[1], 18F-floretyrosine or 18F
Australian Supply Chains Plagued by Data Accessibility Problems, Appian Study Reveals
66% of Supply Chain Professionals Work with Incomplete or Inaccessible Data SYDNEY, Aug. 28, 2024 /PRNewswire/ — New research from Appian (Nasdaq: APPN) reveals that Australian supply chains are crippled by data accessibility issues, with 66% of surveyed supply chain employees stating that th
Everest Medicines Announces Interim Results for First Half of 2024
SHANGHAI, Aug. 27, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results fo
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Aug. 27, 2024 /CNW/ – TSX VENTURE COMPANIES BULLETIN V2024-2570 BIOSYENT INC. (“RX”)BULLETIN TYPE: Declaration of DividendBULLETIN DATE: August 27, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend per Common Share: $0.04
Media Advisory – Deputy Prime Minister’s itinerary for Wednesday, August 28, 2024
OTTAWA, ON, Aug. 27, 2024 /CNW/ – Note: All times local. Toronto, Ontario 1:00 p.m. The Deputy Prime Minister will tour a local housing development site. Closed to media. This document is also available at https://deputypm.canada.ca/en SOURCE Deputy Prime Minister’s Office
STM Investors Have Opportunity to Lead STMicroelectronics N.V. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Aug. 27, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against STMicroelectronics N.V. (“STMicroelectronics” or “the Company”) (NYSE: STM) violations of §§10(b) and 20
